X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank70
Studio
Year-over-Year Change

Free cash flow yield

Latest
-50.61%
↑ 64% vs avg
Percentile
P70
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-141.09%
Historical baseline
PeriodValueYoY Change
2025-50.61%+43.1%
2024-88.96%-37.4%
2023-64.76%+48.5%
2022-125.71%+10.4%
2021-140.36%-201.1%
2020-46.62%-17.9%
2019-39.53%+94.3%
2018-698.89%-672.6%
2017-90.46%-39.3%
2016-64.96%-